BioAmber Inc.
BIOA.WS
BIOA.WS was delisted on the 3rd of May, 2017.
9 hedge funds and large institutions have $2.26M invested in BioAmber Inc. in 2016 Q3 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 1 closing their positions.
27% more capital invested
Capital invested by funds: $1.78M → $2.26M (+$478K)
10% less funds holding
Funds holding: 10 → 9 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LCS
Levin Capital Strategies
New York
|
-$10.7K |
| 2 |
PRCM
Pine River Capital Management
Minnetonka,
Minnesota
|
-$2.17K |
BIOA.WS Hedge Fund Activity: Q3 2016 in Review
9 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in BioAmber Inc. (BIOA.WS) for Q3 2016, worth a combined $2.26M — up 27% from $1.78M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of BIOA.WS and 0 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 0 added.
The largest seller was Levin Capital Strategies, cutting an estimated $10.7K.
- 9 institutional investors held BioAmber Inc. (BIOA.WS) as of Q3 2016, down from 10 in Q2 2016.
- Funds reported $2.26M of BioAmber Inc. stock for Q3 2016, up 27% quarter-over-quarter.
- 0 funds opened new BioAmber Inc. positions in Q3 2016 and 1 closed out, a net change of -1 holder.
- The largest BioAmber Inc. seller in Q3 2016 was Levin Capital Strategies, an estimated $10.7K sold.
Based on aggregated 13F filings for Q3 2016.